PER
Click for more information
1.41% 7.0¢ percheron therapeutics limited

Biomarker, page-5

  1. Akki
    35,729 Posts.
    lightbulb Created with Sketch. 554
    clock Created with Sketch.
    12/11/18
    09:40
    Post #: 36466845
    At $16m mc it’s just silly funded out through the phase 2 trial and into the end of next year. It’s all about DMD and the data even at $0.27 it might be $100m mc but that’s less than 1% of Sarpepta’s valuation and Exondy’s is their only drug in market and only works with 13% of patients.
    ANP Price at posting: 4.5¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

CPV ClearVue shares up 15% as it inks deal to enter Middle East and Indian construction markets
right-arrow Created with Sketch.
POL Polymetals finalises acquisition of Endeavor silver-lead-zinc mine in NSW's Cobar Basin
right-arrow Created with Sketch.
MND Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
right-arrow Created with Sketch.
KAI Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
right-arrow Created with Sketch.
NEWS Second Christmas for 2024 coming to Kalgoorlie: Diggers & Dealers starts Monday
right-arrow Created with Sketch.
GML Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.0¢ 		Change
-0.001(1.41%) 		Mkt cap ! $63.10M
Open High Low Value Volume
7.1¢ 7.1¢ 6.9¢ $34.01K 486.5K

Buyers (Bids)

No. Vol. Price($)
2 132919 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 78000 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.